Pfizer Limited

₹3,904As of Sun 8 Nov 2026, 12:00 UTC
NSE:PFIZERHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 9.66%
Div yield 1.92%
ROE 20.87%
Drug Manufacturers (General)
Beta (5Y) 0.16
PE TTM 20.78
TSR TTM (23.84%)
Mkt cap ₹178.6B
ROIC 52.24%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹3,984
2.05%
(79.76%)
Buy 3|11|10|4|0
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
56.96
58.04
60.56
67.73
21.55%
11.40%
8.01%
18.58%
Revenue₹B
12.83
13.26
13.76
13.80
4.26%
6.48%
5.73%
8.58%
Peers (US$1.879B)
Cap (US$)
PE
2.925B
85.29x
1.885B
9.072x
Capital
TTM
5Y
10Y
Leveragex
0.113
0.220
0.220
EBIT/Intx
4.153
0.178
0.128
Own earn%
29.20
55.38
51.86
Sh yield%
31.37
29.12
28.87
Owners
Insiders/Inst%
11.78
87.57
Short interest%
3.12
SBC / revenue%
5.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
8–10
$1 testx
—
Incr. ROIC%
5